Nano-X Imaging NNOX
NASDAQ NNOX
$0.70 +0.05 (+7.09%)
As of: Sep 30, 2026 · 12:11 PM EDT

Nano-X Imaging (NNOX) EBITDA Margin (2022 - 2026)

Updated

Nano-X Imaging (NNOX) recorded EBITDA Margin of -1267.28% in the quarter ended Jun 30, 2026, down 880.11 percentage points from -387.17% a year earlier and down 994.97 percentage points from the prior quarter.

Analysis

Nano-X Imaging (NNOX) EBITDA Margin (2022 - 2026) Analysis & Trends

On a TTM basis, Nano-X Imaging's EBITDA Margin came in at -692.48% as of Jun 30, 2026, down 304.08 percentage points year-over-year; for the year ended Dec 31, 2025, it was -511.00%, down 112.05 percentage points from the prior year.

  • Annual EBITDA Margin has a five-year change of +2309.32 percentage points (years ended Dec 2020 to Dec 2025).
  • Across earlier years, EBITDA Margin came in at -398.95% in the year ended Dec 31, 2024 (+113.71 pp), -512.66% in the year ended Dec 31, 2023 (+601.71 pp), -1114.37% in the year ended Dec 31, 2022 (+3313.39 pp) and -4427.76% in the year ended Dec 31, 2021 (-1607.44 pp).
  • The figure for the quarter ended Jun 30, 2026 is the lowest quarterly EBITDA Margin since the quarter ended Dec 31, 2022.
  • On a year-over-year basis, EBITDA Margin rose in five of the last eight quarters, with an average year-over-year change of -103.45 percentage points.
  • Peak year-over-year performance for EBITDA Margin in the last five years was a gain of 2067.45 percentage points in the quarter ended Dec 31, 2023, against a drop of 880.11 percentage points in the quarter ended Jun 30, 2026 at the low end.
  • Per Business Quant, the preceding three quarters came in at -272.30% (quarter ended Mar 31, 2026), -875.80% (quarter ended Dec 31, 2025) and -327.15% (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Thermo Fisher Scientific 250.84 Bn 229.99 Bn 4.88 Bn 24.20%
2 Abbott Laboratories 174.73 Bn 145.82 Bn 7.27 Bn 21.86%
3 Danaher 159.85 Bn 143.67 Bn 3.61 Bn 28.51%
4 Intuitive Surgical 146.79 Bn 126.35 Bn 1.96 Bn 41.08%
5 Medtronic 114.54 Bn 80.41 Bn 6.34 Bn 25.55%
6 Stryker 105.67 Bn 91.79 Bn 4.50 Bn 29.67%
7 Boston Scientific 63.93 Bn 58.94 Bn 3.85 Bn 28.17%
8 Becton Dickinson 50.12 Bn 47.27 Bn 2.32 Bn 24.62%
9 Edwards Lifesciences 50.06 Bn 34.17 Bn 1.35 Bn 31.93%
10 Nano-X Imaging 43.84 Mn -135.83 Mn -43.67 Mn -1,267.28%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -1,267.28%
Mar 31, 2026 -272.30%
Dec 31, 2025 -875.80%
Sep 30, 2025 -327.15%
Jun 30, 2025 -387.17%
Mar 31, 2025 -395.99%
Dec 31, 2024 -401.33%
Sep 30, 2024 -369.78%
Jun 30, 2024 -429.01%
Mar 31, 2024 -398.98%
Dec 31, 2023 -316.60%
Sep 30, 2023 -770.31%
Jun 30, 2023 -578.00%
Mar 31, 2023 -374.74%
Dec 31, 2022 -2,384.05%
Sep 30, 2022 -695.41%
Jun 30, 2022 -878.77%
Mar 31, 2022 -1,055.48%
API Access

Nano-X Imaging EBITDA Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda-margin&ticker=NNOX&period=max&api_key=YOUR_API_KEY